Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Dec 7, 2009
Clinical News
Nodlin: Phase I start
...oral Nodlin in up to 26 healthy volunteers. Shanghai Biolaxy is a subsidiary of
NOD Pharmaceuticals
.
NOD Pharmaceuticals Inc.
...
Read More
BioCentury
|
Feb 12, 2007
Finance
Early exits on China plays
...and Schering-Plough Corp. (SGP, Kenilworth, N.J.). Finally, BioVeda led a $5.5 million B round for
NOD Pharmaceuticals Inc.
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Dec 7, 2009
Clinical News
Nodlin: Phase I start
...oral Nodlin in up to 26 healthy volunteers. Shanghai Biolaxy is a subsidiary of
NOD Pharmaceuticals
.
NOD Pharmaceuticals Inc.
...
Read More
BioCentury
|
Feb 12, 2007
Finance
Early exits on China plays
...and Schering-Plough Corp. (SGP, Kenilworth, N.J.). Finally, BioVeda led a $5.5 million B round for
NOD Pharmaceuticals Inc.
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page